Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 2Active not recruiting 2Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Lung Neoplasms 4Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Ovarian Neoplasms 2Mesothelioma, Malignant 2Fallopian Tube Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Vomiting 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Tongue Neoplasms 1Sarcoma 1Rhabdomyosarcoma 1Rectal Neoplasms 1Pelvic Neoplasms 1Oropharyngeal Neoplasms 1Nausea 1Nasopharyngeal Carcinoma 1Mesothelioma 1Medulloblastoma 1Lymphoid Interstitial Pneumonia 1Liposarcoma 1Head and Neck Neoplasms 1Extensive Stage Lung Small Cell Carcinoma 1Esophageal Neoplasms 1Desmoplastic Small Round Cell Tumor 1Colonic Neoplasms 1Cholangiocarcinoma 1

Interventions

Trastuzumab 78Capecitabine 59Cyclophosphamide 54Paclitaxel 52Docetaxel 50Letrozole 44Fulvestrant 43Lapatinib 34Doxorubicin 31Carboplatin 31Vinorelbine 30Bevacizumab 29Anastrozole 28pembrolizumab 26exemestane 24Tamoxifen 23Gemcitabine 22Radiotherapy 21Albumin-Bound Paclitaxel 19Taxes 17Everolimus 17Epirubicin 15pertuzumab 13Ado-Trastuzumab Emtansine 13130-nm albumin-bound paclitaxel 13palbociclib 12Magnetic Resonance Spectroscopy 12liposomal doxorubicin 11atezolizumab 11Filgrastim 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Breast Neoplasms × Platinum × Clear all
NCT06351332 2026-06-04

ZAP-IT: ZN-c3 + Carboplatin + Pembrolizumab in mTNBC

Dana-Farber Cancer Institute

Phase 1 Terminated
7 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡